Obesity rate is declining as more Americans use weight loss drugs, survey finds
As more Americans turn to weight loss drugs, the U.S. adult obesity rate is declining, according to new survey data from Gallup.
Weight Loss
Costco to sell weight loss drugs
Shoppers can now find Ozempic and Wegovy at Costco. It says it is partnering with drugmaker Novo Nordisk to offer the drugs at a steep discount for members with a prescription. CBS News reporter Andres Gutierrez has more.
Is microdosing weight loss drugs safe?
There is a growing trend of microdosing with Ozempic and other popular weight loss drugs. People are taking much smaller amounts, or splitting up doses, to save money or cut down on side effects. CBS News medical contributor Dr. Celine Gounder addresses safety concerns and if the strategy works.
Drugs with weight loss side effects in demand
Medications that have a side effect of weight loss have seen a recent influx of popularity. Some manufacturers say they're having difficulty keeping up with increased demand as the medications become more normalized as a way to lose weight even though that's not the primary purpose for them. Dr. Lisa Palmer, a psychotherapist and founder of the Renew Center of Florida, joined CBS News to talk about the risks.
Serena Williams speaks on GLP-1s
Serena Williams made headlines this week, not for her tennis court achievements, but for her health challenges since giving birth to her two children. She revealed she lost about 30 pounds by using a GLP-1 medication, such as Wegovy and Zepbound, through the telehealth company Ro. She serves as a paid spokesperson. CBS News' Dr. Céline Gounder has more.
Serena Williams reveals she's using weight loss drugs and addresses stigma
Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.
Doctor on ultra-processed foods
Some new studies and data out this week are giving fresh insight into ultra-processed foods. A major clinical trial conducted in the United Kingdom found that diets containing ultra-processed foods are associated with increased cravings and higher calorie consumption. CBS News medical contributor Dr. Celine Gounder has expert takeaways.
Eli Lilly weight loss pill shows promise in latest clinical trial
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.
Positive results for new weight loss pill
Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a pill. Dr. Jon LaPook reports.
Timeline for weight loss-diabetes pill
A first-of-its-kind pill from Eli Lilly that addresses weight loss and diabetes is showing signs of success at its clinical trial. CBS News medical contributor Dr. Celine Gounder breaks down what to know.
New pricing for popular weight loss drug
Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' Nancy Chen reports on the qualifications for the discount and what the cost reduction will be.
Drug for extreme hunger offers clues to obesity's complexity
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger.
Could weight loss drugs help prevent cancer? Here's what a new study found.
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Trump won't force Medicaid to cover GLP-1s for obesity. A few states are.
Late last year, South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But access remains limited.
Patients fear losing affordable weight loss drugs
Weight loss drugs for many people may soon get a lot more expensive -- a shortage of them had actually led to lower prices. Kris Van Cleave explains how that happened and why prices could go up.
Weight loss drugs have "no end game," former FDA commissioner warns
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus."
Zepbound tops Wegovy for weight loss in study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Study compares weight loss drugs
A new study from the New England Journal of Medicine compares two weight loss drugs, Tirzepatide and Semaglutide. CBS News medical contributor Dr. Celine Gounder breaks down the findings.
WeightWatchers declares bankruptcy as people embrace weight loss drugs
WeightWatchers, founded in 1963, has struggled to shed debt and cope with the emergence of weight loss drugs.
Weight loss drugs could help liver disease
A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for obesity could also help people with a type of liver disease. CBS News contributor Dr. Celine Gounder explains the findings.
GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
Obesity doctor touts new weight loss drug
There may soon be a new medication option for losing weight. Eli Lilly's experimental pill appears to work as well as the injected drug Ozempic to lower the weight of diabetes patients. Dr. Jon LaPook has more.
New weight loss pill found effective in trial
A new clinical trial is showing promising results for a new pill to help treat diabetes and support weight loss. CBS News chief medical correspondent Dr. Jon LaPook explains.
Can weight loss drugs help with dementia risk? Here's what studies suggest.
Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.
Weight loss drugs could help curb dementia
Two new studies in JAMA Neurology show some diabetes and popular weight loss drugs could help to protect against dementia. CBS News medical contributor Dr. Celine Gounder joins "CBS Mornings" to explain what researchers found.
Texas dad deported to Ghana was then forced to go to Mali, he says
Poll finds Democrats still boosted by voters' economic concerns
Lula wins 4th term as Brazil's president, but Bolsonaro rejects results
Live
Iran shrugs off Trump's attack threats, says diplomacy ongoing
Venezuela opposition leader María Corina Machado returns to country
Blanche says DOJ is "doing our own research" with Alaska challenge
More than 1,000 arrested in France as protesters and police clash
Jordan says 3 arrested in deadly attack on Greek Orthodox church
